September 6th, 2011 by BobDoherty in Health Policy, Opinion
Tags: ACP, Carl Elliott, Clinical Trials, Disclosures, Ethics, Income, Industry-funding, Medical-Industrial Complex, New York Times, Physician-Investigator payment, Research Participants, Seeding Trials, Seton Hall's Center for Health and Pharmaceutical Law & Policy, University of Minnesota
No Comments »
Follow the money.
Earlier this week, I blogged about the growing economic relationships and even mutual dependency between medical device manufactures and physicians, citing a pre-emptive strike against an Institute of Medicine report that recommended closer regulation of medical devices before and after they enter the market. Such ties, though, are only one part of a broader medical-industrial complex that has enormous impact on public policy in the United States.
A 2009 White Paper by the Seton Hall’s Center for Health & Pharmaceutical Law & Policy reported that “ drug and medical device companies fund up to 80% to 90% of all clinical trials; in 2005, and that by 2004, three-quarters of all of the clinical trials paid for by industry were in private physician practices or for-profit research centers.” The paper’s authors argue that such trials “create potential conflicts of interest that possibly jeopardize the rights and well-being of research participants as well as the integrity of research results” and that “the goal for public policy should be to structure physician-investigator payment to achieve financial neutrality between treatment and research.”
A recent web posting by a medical billing company unabashedly crows about the extra income doctors can make from clinical trials. Read more »
*This blog post was originally published at The ACP Advocate Blog by Bob Doherty*
September 6th, 2011 by Stanley Feld, M.D. in Health Policy, Opinion
Tags: Aetna, AMA, American Medical Association, Blue Cross Blue Shield, Cigna, Controlling Waste, Health Care Service Corp., Health Insurance, Humana, Insurance Claims, Insurance Companies, Medical Loss Ratio, Medicare, Net Profit, Payment Accuracy, Payment Efficiency, RAND report, Regence Group, UnitedHealthcare
No Comments »
I have described how the healthcare insurance industry loads its expenses into direct patient care expenses to increase their profits.
The Medical-Loss Ratio calculation is not reported by the traditional media. The healthcare insurance industry spends less healthcare dollars on direct patient care after it is permitted by federal and local agencies to load its expenses into the direct patient care column.
Simply put, the healthcare insurance industry cooks the books to increase its net profit.
Another way to increase profits is to shortchange physicians on medical claims. In fact, 20% of medical claims payments are inaccurate according to the American Medical Association’s (AMA) fourth annual National Health Insurer Report Card. Claims-processing errors by health insurance companies waste billions of dollars and frustrate patients and physicians.
This is one of the reasons the RAND report about physicians controlling waste is so absurd to me. The healthcare insurance industry creates waste in order to increase net profit. Read more »
*This blog post was originally published at Repairing the Healthcare System*
September 5th, 2011 by AndrewSchorr in Opinion
Tags: Acceptance, Cancer, Death, Fight, Giving Up, Outlook, Remission, Resignation, Stepping Down, Steve Jobs, Survival, Terminal Condition, Treatment
No Comments »
Steve Jobs in 2010
It was a bombshell that shouldn’t have been unexpected. Steve Jobs resigning. Anyone who saw him knew he was sick and, just watching him on television, it was obvious to me he was getting sicker. When you get so thin, when your color is not good, when you are probably taking heavy duty drugs that have side effects, you certainly don’t feel good. And when you don’t feel good, it is tough to think clearly, and make decisions with certainty. That is not a good thing for the CEO of one of the most successful corporations. It is actually a tribute to his will that he carried on so long. Many of the rest of us would be on a beach, taking it easy and celebrating every day. Steve Jobs celebrated every day by running Apple.
But at some point, given life is a terminal condition anyway, you have to accept that “the beast,” whatever it is in your case, is winning. I know that for myself. I have had a long remission with leukemia. But I know it could come back and even newer drugs might not “win.” I am thankful for the success treatment has had for so long. And I am sure Steve Jobs is thankful his diagnosis several years ago didn’t lead to his demise right then. We thank him, too, for iPhones and iPads and several other wonderful gizmos he has in the works that will blossom in the future.
Knowing when to call it quits – not accepting death – but accepting disability or a need to spend time differently – is a hard part of being a patient, it stinks. But it is reality. Read more »
*This blog post was originally published at Andrew's Blog*
September 4th, 2011 by Berci in Opinion
Tags: Children, Comic Books, Diagnosis, Education, Explanation, Medicine, Medicine 2.0, Medikidz, Prevention, Superheroes, Treatment, Understanding Illness, Web 2.0
1 Comment »
I’ve recently come across Medikidz, a fantastic initiative with a mission to help children understand medical information, especially diseases. I cannot imagine a better way to promote such important messages to children.
Millions of children worldwide are diagnosed every day with conditions that even their parents may find difficult to comprehend. Most children don’t understand their medical conditions, or associated investigations, procedures and treatments, and are often scared by what is going on around them.
That is where the Medikidz come into action!
The Medikidz are Read more »
*This blog post was originally published at ScienceRoll*
September 4th, 2011 by John Mandrola, M.D. in Opinion
Tags: ACE inhibitor, Aspirin, Beta Blocker, Dr. Salim Yusef, Exercise, Healthy Living, Heart Disease Prevention, ICD Patients, Michael O’Riordan, Polypill, Secondary Prevention, Statin, TheHeart.org
1 Comment »
The tweet said that experts were debating the merits of a polypill? I had to click that link.
Yes. I was right; there were actually “eminent” cardiologists suggesting that a pill containing 4 different medicines (a statin, aspirin, beta-blocker and an ACE-inhibitor) “might change the face of cardiovascular medicine.”
The direct quote from Dr. Salim Yusef, one of the most eminent heart doctors, went like this:
“We have to think of the polypill not as a pill, but as part of a strategy to completely change our approach to prevention,” said Yusuf. “Instead of saying lifestyle first and drugs next, why don’t we say that drugs are the basis, then get the patients contemplating prevention, and then get them to modify their lifestyle. Maybe that will work, because the reverse strategy hasn’t.”
Maybe it was jet lag? Read more »
*This blog post was originally published at Dr John M*
